Nuvectis Pharma, Inc. (NVCT )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol NVCT
- Company Nuvectis Pharma, Inc.
- Price $5.39
- Changes Percentage -0.37
- Change -0.02
- Day Low $5.33
- Day High $5.89
- Year High $12.1
- Year Low $4.44
- Market Cap $104,140,039
- Price Avg 50 EMA (D) $6.22
- Price Avg 200 EMA (D) $6.65
- Exchange NASDAQ
- Volume 111,622
- Average Volume 175,572
- Open $5.45
- Previous Close $5.41
- EPS -1.16
- PE -4.65
- Earnings Announcement 2025-03-04 05:00:00
- Shares Outstanding $19,320,972
Company brief: NUVECTIS PHARMA, INC. (NVCT )
- Healthcare
- Biotechnology
- Mr. Ron Bentsur M.B.A.
- https://www.nuvectis.com
- US
- N/A
- 02-04-2022
- US67080T1088
Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src and YES1 kinases. The company was incorporated in 2020 and is based in Fort Lee, New Jersey.